While Zynerba Hits on ASD; SanaCurrents Suspending Coverage of CONNECT-FX
On Wednesday, May 27, Zynerba (NASDAQ:ZYNE) reported positive data from [...]
Call Us: (800) 891-1526
M - F 8AM to 4PM ET
SanaCurrents Adds ASD Phase II Trial as a Catalyst for Zynerba (ZYNE)
Zynerba Catalyst Update Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) recently affirmed it [...]
-
Acceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020 GalleryAcceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020
Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates
Acceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020
Onconova Coverage suspended, Oragenics falls short in Phase II trial. [...]
-
Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) – 3Q 2019 catalyst, CBD treatment for Fragile X GalleryZynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) – 3Q 2019 catalyst, CBD treatment for Fragile X
Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment
Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) – 3Q 2019 catalyst, CBD treatment for Fragile X
3Q ‘19 catalyst, CBD treatment for Fragile X SanaCurrents is [...]